Developer docs
API playgroundTry for free, no card

Search company profiles

Kivo

Full company profile

uuid00042ev

Namestring
Kivo
Legal namestring
Kivo, Inc.
Websiteurl
kivo.io
Company typeenum
Private
Founded yearint
2021
Descriptiontext

Kivo is a private, Delaware-incorporated SaaS company headquartered in Portland, Oregon, founded in 2021 to deliver cloud-based document and process management for life sciences organizations. The platform unifies four core modules — Document Management System (DMS), Regulatory Information Management (RIM), electronic Trial Master File (eTMF), and Quality Management System (QMS) — under a single all-inclusive subscription priced from $1,800 per month, with no per-module fees. Built on the EDM Reference Model and aligned to 21 CFR Part 11, EU Annex 11, GxP, GCP, ICH, SOC 2 Type 2, ISO 9001, and ISO 27001, Kivo combines lifetime validation with each release, Microsoft Office Online collaborative editing, embedded DocuSign Part-11 e-signatures (and, as of April 2026, native Part 11 e-signatures), an eCTD 4.0 viewer, a Submission Builder, and more than 450 ICH document templates.

The company serves more than 100 sponsors and service providers across the U.S., Europe, and Asia, managing over 100 active drug applications to the FDA, EMA, MHRA, and Health Canada. Customers span mid-market biotech (Elevar, Ventus, Fulcrum, Astria, Morphic Therapeutics, HDT Bio, Artiva, Azura, Durect, STAR Therapeutics, Trevi, Arbor Biotech), enterprise CROs (Labcorp), and life sciences consultants. Kivo sells through direct enterprise sales with demo-driven engagement, targeting teams that have been underserved by legacy RIM and QMS platforms that cost 10x more and take 6-12 months to implement versus Kivo's typical two-week onboarding. Revenue is generated through SaaS subscription contracts that bundle implementation, validation, training, and support.

Kivo has raised approximately $11.2 million across a 2022 seed round co-led by Facet Life Sciences and Oregon Venture Fund, a 2024 follow-on, and a December 2025 SEC Form D filing of roughly $5.1 million. The company maintains a lean team of 1-10 employees and operates Headless GxP, an architectural initiative positioning the platform as a compliant system of record that any tool, model, or agentic workflow can integrate with via MCP. Operations continue with a steady quarterly release cadence from 2022 through 2026.Q2.

Short descriptiontext

Kivo is a Portland-based SaaS provider of unified document, regulatory, trial master file, and quality management software for life sciences companies. Its all-inclusive platform offers Part 11 compliant e-signatures, lifetime validation, and Headless GxP architecture for agentic AI workflows.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersPortland, United States
HQ citystring
Portland
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
regulatory information management, clinical document management, trial master file software, life sciences quality management, pharma regulatory submissions
Industry1 code
PRIMARYHLAGAJAB
Electronic Lab Notebooks (ELN)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
NAICS code1 code
  • Software Publishers5132
SIC code2 codes
  • Services-Computer Programming, Data Processing, Etc.7370
  • Services-Computer Programming Services7371
Product category
Life Sciences Regulatory Software
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1SaaS Subscription
TypeSubscription Recurring
Description

Kivo operates as a Software-as-a-Service (SaaS) company charging subscription fees for access to their platform. The subscription includes all modules (DMS, RIM, eTMF, QMS) with additional modules able to be turned on at any time. Implementation, setup, maintenance, continuous validation, training, and support are included in the subscription price.

kivo.io
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1Team plans starting under $1,000/month
ModelSubscriptionBilling cadenceMonthly
Notes

Team plans start at $1,800/month with transparent, all-inclusive pricing. Legacy RIM platforms often require six-figure budgets with thousands in hidden costs.

kivo.io
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Kivo provides an all-in-one cloud-based document and process management SaaS platform for life sciences organizations. The platform unifies Document Management System (DMS), Regulatory Information Management (RIM), electronic Trial Master File (eTMF), and Quality Management System (QMS) capabilities, with native 21 CFR Part 11 compliance and add-on modules for regulatory submissions, training, and correspondence.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Validation time reduced by 80-90%
+3 more records
Product overview1 text field

Kivo is an all-in-one, SaaS-based document and process management platform designed specifically for life sciences organizations. The platform operates as a unified system with four core integrated modules: DMS (Document Management System) for controlled document management with Part-11 compliant e-signatures, RIM (Regulatory Information Management) for regulatory submissions and lifecycle management, eTMF (electronic Trial Master File) for clinical trial document management, and QMS (Quality Management System) for quality oversight and compliance. All modules are included in the subscription with no per-module pricing. The platform also offers Headless GxP as a modern architecture initiative for agentic AI workflows, plus specialized add-on capabilities including an eCTD Viewer, Submission Builder, over 450 ICH Document Templates, Training Management, and Correspondence Management. The platform is browser-based, requires no IT deployment, and supports both PC and Mac environments.

Product and service10 records
1Document Management System (DMS)
2Regulatory Information Management (RIM)
3Electronic Trial Master File (eTMF)
4Quality Management System (QMS)
5Headless GxP
6eCTD Viewer
7Submission Builder
8ICH Document Templates
9Training Management
10Correspondence Management
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
1DocuSign
Strategic tierCoreTypeTechnology or Integration
Description

DocuSign integration provides Part 11 compliant electronic signatures embedded directly in the Kivo platform. Kivo includes DocuSign licenses with no separate license required, enabling compliant e-signatures for document approvals.

kivo.io
Strategic tierCoreTypeTechnology or Integration
Description

Deep integration with Microsoft Office Online for real-time collaborative editing of documents directly in the browser. Also supports Microsoft Office 365 for local editing.

3EDM Reference Model / GxP Standards
Strategic tierCoreTypeTechnology or Integration
Description

Kivo is built on the Electronic Document Management (EDM) Reference Model and GxP Standards, ensuring alignment with industry compliance requirements.

kivo.io
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Kivo partners with external publishing vendors that customers use for final eCTD publishing. Kivo's platform supports easy publishing exports and eCTD re-import for seamless handoff to preferred publishers.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Qualio offers a cloud QMS with document and training management aimed at life sciences, sharing Kivo's focus on emerging and mid-market sponsors and intuitive UX.

TypeDirect peer
Description

Veeva's Vault platform is the dominant RIM, QMS, eTMF, and document management suite for life sciences. It competes directly with Kivo across every core module, but is built for large pharma with enterprise pricing and longer implementations.

TypeDirect peer
Description

ComplianceQuest delivers a Salesforce-native QMS, document, and training management platform for life sciences and manufacturing, competing with Kivo's QMS and document automation capabilities.

TypeOthers
Description

Box is a general-purpose content management platform with regulated-industry capabilities that some life sciences teams use alongside or as an alternative to Kivo's DMS module for controlled documents.

TypeDirect peer
Description

MasterControl provides QMS, document control, and compliance software for life sciences manufacturers and is one of the legacy players Kivo explicitly positions against on cost and ease of use.

TypeDirect peer
Description

Greenlight Guru provides QMS and document control purpose-built for medical device companies, overlapping with Kivo's life sciences QMS and DMS capabilities in the regulated-document workflow space.

TypeDirect peer
Description

Dot Compliance provides AI-enabled QMS and regulatory document management for life sciences, overlapping with Kivo's QMS and RIM modules, especially for mid-sized sponsors.

TypeBroad incumbent
Description

Medidata provides clinical trial platforms (Rave, eTMF) within the broader Dassault 3DEXPERIENCE life sciences stack. It overlaps with Kivo's eTMF module as a much larger incumbent in clinical operations.

9DocuSign
TypeOthers
Description

DocuSign is both a Kivo integration partner for Part 11 e-signatures and a broader workflow/e-signature provider that overlaps with Kivo's document approval capabilities in adjacent use cases.

TypeDirect peer
Description

PTC's Arena solution offers PLM, quality, and document management for life sciences and medical devices, competing with Kivo's DMS and QMS in regulated document and change-control workflows.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers19 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance7 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors6 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Kivo

Life Sciences Regulatory Softwarekivo.io

Kivo is a Portland-based SaaS provider of unified document, regulatory, trial master file, and quality management software for life sciences companies. Its all-inclusive platform offers Part 11 compliant e-signatures, lifetime validation, and Headless GxP architecture for agentic AI workflows.

What Kivo does

Kivo is a private, Delaware-incorporated SaaS company headquartered in Portland, Oregon, founded in 2021 to deliver cloud-based document and process management for life sciences organizations. The platform unifies four core modules — Document Management System (DMS), Regulatory Information Management (RIM), electronic Trial Master File (eTMF), and Quality Management System (QMS) — under a single all-inclusive subscription priced from $1,800 per month, with no per-module fees. Built on the EDM Reference Model and aligned to 21 CFR Part 11, EU Annex 11, GxP, GCP, ICH, SOC 2 Type 2, ISO 9001, and ISO 27001, Kivo combines lifetime validation with each release, Microsoft Office Online collaborative editing, embedded DocuSign Part-11 e-signatures (and, as of April 2026, native Part 11 e-signatures), an eCTD 4.0 viewer, a Submission Builder, and more than 450 ICH document templates.

The company serves more than 100 sponsors and service providers across the U.S., Europe, and Asia, managing over 100 active drug applications to the FDA, EMA, MHRA, and Health Canada. Customers span mid-market biotech (Elevar, Ventus, Fulcrum, Astria, Morphic Therapeutics, HDT Bio, Artiva, Azura, Durect, STAR Therapeutics, Trevi, Arbor Biotech), enterprise CROs (Labcorp), and life sciences consultants. Kivo sells through direct enterprise sales with demo-driven engagement, targeting teams that have been underserved by legacy RIM and QMS platforms that cost 10x more and take 6-12 months to implement versus Kivo's typical two-week onboarding. Revenue is generated through SaaS subscription contracts that bundle implementation, validation, training, and support.

Kivo has raised approximately $11.2 million across a 2022 seed round co-led by Facet Life Sciences and Oregon Venture Fund, a 2024 follow-on, and a December 2025 SEC Form D filing of roughly $5.1 million. The company maintains a lean team of 1-10 employees and operates Headless GxP, an architectural initiative positioning the platform as a compliant system of record that any tool, model, or agentic workflow can integrate with via MCP. Operations continue with a steady quarterly release cadence from 2022 through 2026.Q2.

Kivo firmographics

Firmographics
Name
Kivo
Legal name
Kivo, Inc.
Website
https://kivo.io
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
11–50 employees
Short description
Kivo is a Portland-based SaaS provider of unified document, regulatory, trial master file, and quality management software for life sciences companies. Its all-inclusive platform offers Part 11 compliant e-signatures, lifetime validation, and Headless GxP architecture for agentic AI workflows.
Ownership category
akta.pro rank

Kivo industry classification

Industry
Product category
Life Sciences Regulatory Software
NAICS
Software Publishers (5132)
SIC
Services-Computer Programming, Data Processing, Etc. (7370), Services-Computer Programming Services (7371)
akta.pro industry
PRIMARYHLAGAJAB
Electronic Lab Notebooks (ELN)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

Keywords

  • Regulatory information management
  • Clinical document management
  • Trial master file software
  • Life sciences quality management
  • Pharma regulatory submissions

Where Kivo is headquartered

Location

Headquarters

HQ city
Portland
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Kivo business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. SaaS Subscription: Kivo operates as a Software-as-a-Service (SaaS) company charging subscription fees for access to their platform. The subscription includes all modules (DMS, RIM, eTMF, QMS) with additional modules able to be turned on at any time. Implementation, setup, maintenance, continuous validation, training, and support are included in the subscription price.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyTeam plans starting under $1,000/month

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Kivo product offering

Product offering

Core offering

Kivo provides an all-in-one cloud-based document and process management SaaS platform for life sciences organizations. The platform unifies Document Management System (DMS), Regulatory Information Management (RIM), electronic Trial Master File (eTMF), and Quality Management System (QMS) capabilities, with native 21 CFR Part 11 compliance and add-on modules for regulatory submissions, training, and correspondence.

Product overview

Kivo is an all-in-one, SaaS-based document and process management platform designed specifically for life sciences organizations. The platform operates as a unified system with four core integrated modules: DMS (Document Management System) for controlled document management with Part-11 compliant e-signatures, RIM (Regulatory Information Management) for regulatory submissions and lifecycle management, eTMF (electronic Trial Master File) for clinical trial document management, and QMS (Quality Management System) for quality oversight and compliance. All modules are included in the subscription with no per-module pricing. The platform also offers Headless GxP as a modern architecture initiative for agentic AI workflows, plus specialized add-on capabilities including an eCTD Viewer, Submission Builder, over 450 ICH Document Templates, Training Management, and Correspondence Management. The platform is browser-based, requires no IT deployment, and supports both PC and Mac environments.

Differentiator

Problem solved

Functional benefit

Products and services

  • Document Management System (DMS)
  • Regulatory Information Management (RIM)
  • Electronic Trial Master File (eTMF)
  • Quality Management System (QMS)
  • Headless GxP
  • eCTD Viewer
  • Submission Builder
  • ICH Document Templates
  • Training Management
  • Correspondence Management

Quantifiable outcome

  • Validation time reduced by 80-90%
  • +3 more outcomes

Companies that use Kivo

Customer profile

Named customers19 records

Segments5 records

Ideal customer profiles2 records

Kivo technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability3 records

Feature7 records

Kivo partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and minor.

  • DocuSigncoreTechnology or IntegrationDocuSign integration provides Part 11 compliant electronic signatures embedded directly in the Kivo platform. Kivo includes DocuSign licenses with no separate license required, enabling compliant e-signatures for document approvals.
  • MicrosoftcoreTechnology or IntegrationDeep integration with Microsoft Office Online for real-time collaborative editing of documents directly in the browser. Also supports Microsoft Office 365 for local editing.
  • EDM Reference Model / GxP StandardscoreTechnology or IntegrationKivo is built on the Electronic Document Management (EDM) Reference Model and GxP Standards, ensuring alignment with industry compliance requirements.
  • Publishing Vendors (e.g., Docubridge)minorChannel Partner/ Reseller/ DistributorKivo partners with external publishing vendors that customers use for final eCTD publishing. Kivo's platform supports easy publishing exports and eCTD re-import for seamless handoff to preferred publishers.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Kivo competitors and assessment

Company assessment

Direct peers

  • Qualio: Qualio offers a cloud QMS with document and training management aimed at life sciences, sharing Kivo's focus on emerging and mid-market sponsors and intuitive UX.
  • Veeva Systems: Veeva's Vault platform is the dominant RIM, QMS, eTMF, and document management suite for life sciences. It competes directly with Kivo across every core module, but is built for large pharma with enterprise pricing and longer implementations.
  • ComplianceQuest: ComplianceQuest delivers a Salesforce-native QMS, document, and training management platform for life sciences and manufacturing, competing with Kivo's QMS and document automation capabilities.
  • MasterControl: MasterControl provides QMS, document control, and compliance software for life sciences manufacturers and is one of the legacy players Kivo explicitly positions against on cost and ease of use.
  • Greenlight Guru: Greenlight Guru provides QMS and document control purpose-built for medical device companies, overlapping with Kivo's life sciences QMS and DMS capabilities in the regulated-document workflow space.
  • Dot Compliance: Dot Compliance provides AI-enabled QMS and regulatory document management for life sciences, overlapping with Kivo's QMS and RIM modules, especially for mid-sized sponsors.
  • PTC Arena: PTC's Arena solution offers PLM, quality, and document management for life sciences and medical devices, competing with Kivo's DMS and QMS in regulated document and change-control workflows.

Others

  • Box: Box is a general-purpose content management platform with regulated-industry capabilities that some life sciences teams use alongside or as an alternative to Kivo's DMS module for controlled documents.
  • DocuSign: DocuSign is both a Kivo integration partner for Part 11 e-signatures and a broader workflow/e-signature provider that overlaps with Kivo's document approval capabilities in adjacent use cases.

Broad incumbents

  • Medidata Solutions (Dassault Systèmes): Medidata provides clinical trial platforms (Rave, eTMF) within the broader Dassault 3DEXPERIENCE life sciences stack. It overlaps with Kivo's eTMF module as a much larger incumbent in clinical operations.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Kivo social profiles

Digital presence

Kivo compliance and trust

Trust signal

Compliance7 records

Kivo financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Kivo leadership team

Management profile

Number of profiles

Profiles2 records

Kivo funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Kivo M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kivo

What does Kivo do?

Kivo provides an all-in-one cloud-based document and process management SaaS platform for life sciences organizations. The platform unifies Document Management System (DMS), Regulatory Information Management (RIM), electronic Trial Master File (eTMF), and Quality Management System (QMS) capabilities, with native 21 CFR Part 11 compliance and add-on modules for regulatory submissions, training, and correspondence.

Is Kivo a public or private company?

Kivo is a private company. It is classified as venture growth investor backed and is currently operating.

When was Kivo founded?

Kivo was founded in 2021. It employs 11 to 50 people.

Where is Kivo based?

Kivo is headquartered in Portland, United States, in the North America region.

How does Kivo make money?

One revenue line is on record: saaS Subscription.

Who are Kivo's main competitors?

Direct peers on record are Qualio, Veeva Systems, ComplianceQuest, MasterControl, Greenlight Guru, Dot Compliance and PTC Arena. Others are Box and DocuSign. Medidata Solutions (Dassault Systèmes) is listed as a broad incumbent.

Does Kivo have an API?

Yes. Kivo offers APIs for GxP-compliant data import-export, enabling seamless data flow across regulatory, quality, and clinical operations. The API supports integrations with QMS, CTMS, ERP, and other critical systems. Single Sign-On (SSO) is also available for enterprise authentication.

What industry is Kivo in?

Kivo's product category is Life Sciences Regulatory Software. Its primary akta.pro industry code is HLAGAJAB, Electronic Lab Notebooks (ELN). Its NAICS code is 5132 and its SIC code is 7370.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
EIN PresswireThe paperwork problem: How many FDA warning letters actually cite document failuresThe FDA issued 303 warning letters to drug and biologics firms in 2025, a 59% increase from the prior year. Kivo's analysis of 2021-2026 data found documentation, recordkeeping, or data integrity issues in at least 94% of letters, with primary citations ranging from 15% to 53%.BioSpaceKivo to Showcase Headless GxP at RAPS Convergence 2026Kivo will exhibit at RAPS Convergence 2026 in Charlotte, North Carolina, September 15-17, at Booth #706. The company will demonstrate its Headless GxP system, an agent-native architecture for life sciences teams to operationalize AI while maintaining GxP compliance. Early-access customers have responded positively since the system launched in June.BioSpaceKivo Joins Experts at RAPS San Francisco to Report on Real-World AI Use Cases in Life SciencesKivo will present at the RAPS San Francisco Bay Area Chapter event on July 29, sharing its experience with AI in life sciences. The company's CEO Toban Zolman said the event aims for honest conversations about AI adoption. Kivo recently introduced Headless GxP, an agent-native architecture for GxP-compliant AI operations.BioSpaceKivo and CRISPR Therapeutics to Present 52-Day QMS Modernization at DIA 2026 in PhiladelphiaKivo and CRISPR Therapeutics will co-present a DIA 2026 session on modernizing quality management systems in 52 days. The session, featuring CRISPR's Kate Ellmer and Kivo's Chris Xistris, highlights CRISPR's rapid QMS implementation. It aims to show how biotech firms can deploy scalable quality systems quickly without sacrificing compliance.EIN PresswireKivo Expands Life Sciences Leadership Team with Appointment of Former Veeva Executive Chris XistrisKivo appointed Chris Xistris as Vice President of Services, bringing over 25 years of experience in regulatory and clinical operations. He previously served as Senior Director, R&D Services Engagement at Veeva Systems, leading adoption across 600+ customer engagements. Kivo is expanding its services organization as demand grows among life sciences organizations.KivoDrug Development Trends for 2025 and BeyondKivo identifies five key trends shaping drug development in 2025, highlighting the acceleration of AI-driven discovery which has attracted over $60 billion in investment and is expected to significantly increase clinical trial volumes. The article notes a resurgence in venture capital funding with a focus on faster exits, alongside industry shifts toward decentralized operations and asset-centric business models. Additionally, it points to potential regulatory uncertainty stemming from political changes as a factor requiring increased agility from pharmaceutical companies.SecSEC FORM DKivo, Inc., a Delaware corporation headquartered in Portland, Oregon, filed a Form D notice with the SEC on December 23, 2025, reporting an exempt offering of Series Seed-2 Preferred securities totaling $5,127,540. Simultaneously, convertible debt previously issued converted to new shares of Series Seed-3 Preferred. The offering, conducted under Regulation D exemption rules, attracted 13 investors with no sales commissions or finder's fees.KivoRegulatory Data Management In Life SciencesThe article discusses the critical importance of unified regulatory data management platforms in the life sciences industry to replace fragmented legacy systems like spreadsheets. It highlights Kivo as a provider offering solutions that consolidate Quality Management Systems (QMS), Regulatory Information Management (RIM), and electronic Trial Master Files (eTMF) into a single source of truth. The text presents case studies from clients Elpida, Hyloris, and Elevar Therapeutics to demonstrate how adopting such platforms accelerates development timelines and ensures compliance with global regulations.KivoRegulatory Document Management Systems ExplainedThe article serves as a promotional guide for Kivo, a regulatory document management system designed specifically for life sciences companies to ensure compliance with regulations like 21 CFR Part 11. It contrasts Kivo's validated, out-of-the-box features against general-purpose tools like SharePoint and enterprise competitors such as Veeva, highlighting benefits in audit readiness and implementation speed. The text positions Kivo as a cost-effective solution that reduces validation burdens for emerging biotechs and clinical teams.